Serial 88801666
Dead / Abandoned — Abandoned — no statement of use filed (as of 12 Feb 2024)
What this means for you
This application is over — abandoned 12 Feb 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88801666
- Mark type
- Design / logo
- Filed
- 18 Feb 2020
- Published for opposition
- 17 Nov 2020
- Abandoned
- 12 Feb 2024
- Attorney of record
- Harold Milstein
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in humans, namely, chemotherapeutics and biopharmaceuticals for the treatment of diseases and conditions, in particular, disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system and for the treatment of cancer, autoimmune diseases, and inflammatory disorders; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology, ophthalmology, gastroenterological disorders, and tissue and organ transplantology
- Class 042 — Scientific and technological services: Biotechnology research, namely, research and development of pharmaceutical preparations for use in humans; research and development of pharmaceutical preparations for the diagnosis, prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, and the genitourinary system; research and development of pharmaceutical preparations for the diagnosis, prevention and treatment of cancer, autoimmune diseases, inflammatory disorders, gastroenterological disorders and for use in dermatology, oncology, hematology, ophthalmology, and tissue and organ transplantation
Owner
- SEAGEN INC., BOTHELL, WA, US
- Seattle Genetics, Inc., Bothell, WA, US
- Seattle Genetics, Inc., Bothell, WA, US
Prosecution history
- 12 Feb 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 12 Feb 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 21 Jun 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Jun 2023 — SOU EXTENSION 5 GRANTED
- 09 Jun 2023 — SOU EXTENSION 5 FILED
- 16 Jun 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 09 Jun 2023 — SOU TEAS EXTENSION RECEIVED
- 13 Jan 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Jan 2023 — SOU EXTENSION 4 GRANTED
- 11 Jan 2023 — SOU EXTENSION 4 FILED
- 11 Jan 2023 — SOU TEAS EXTENSION RECEIVED
- 25 Jun 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Jun 2022 — SOU EXTENSION 3 GRANTED
- 23 Jun 2022 — SOU EXTENSION 3 FILED
- 23 Jun 2022 — SOU TEAS EXTENSION RECEIVED